A phase 1, randomised, placebo-controlled, double-blind, cross-over study to evaluate systemic bioavailability of oral OTS167 under fed and fasting conditions in healthy adult subjects

Trial Profile

A phase 1, randomised, placebo-controlled, double-blind, cross-over study to evaluate systemic bioavailability of oral OTS167 under fed and fasting conditions in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs OTS 167 (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Sponsors OncoTherapy Science
  • Most Recent Events

    • 28 Mar 2016 New trial record
    • 17 Mar 2016 Results published in OncoTherapy Sciences media release.
    • 17 Mar 2016 Status changed from recruiting to completed, as reported by OncoTherapy Sciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top